Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
Status:
Completed
Trial end date:
2017-05-18
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerance of clarithromycin given three times per week in
combination with multiple drugs including rifabutin three times per week
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at Tyler